^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Pancreatic Cancer |
| Drug: | 5-fluorouracil (Thymidylate synthase inhibitor) + oxaliplatin (DNA synthesis inhibitor, DNA cross linking agent) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Metastatic Pancreatic Cancer: ASCO Guideline Update
Published date:
08/05/2020
Excerpt:
Recommendations…Treatment Options After First-Line Therapy…Fluorouracil plus oxaliplatin may be considered as second-line therapy…
DOI:
10.1200/JCO.20.01364 Journal of Clinical Oncology
